Should we modify our indications after the EVAR-2 trial conclusions?

Sobocinski, Jonathan

Should we modify our indications after the EVAR-2 trial conclusions? [electronic resource] - Annals of vascular surgery Jul 2011 - 590-7 p. digital

Publication Type: Comparative Study; Journal Article

1615-5947

10.1016/j.avsg.2010.08.010 doi


Aged
Aged, 80 and over
Aortic Aneurysm, Abdominal--diagnostic imaging
Aortography--methods
Blood Vessel Prosthesis Implantation--adverse effects
Chi-Square Distribution
Endovascular Procedures--adverse effects
Evidence-Based Medicine
France
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Kaplan-Meier Estimate
Patient Selection
Platelet Aggregation Inhibitors--therapeutic use
Randomized Controlled Trials as Topic
Reoperation
Retrospective Studies
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Tomography, X-Ray Computed
Treatment Outcome